Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Out-of-Distribution-aware Reasoning Agents for Clinical Learning and Exploration

Objective

We have recently observed an unexpected and profoundly promising synergy: multi-modal out-of-distribution detection methods, originally developed for normative modelling in the ERC MIA-NORMAL project, appear to endow AI agents with remarkable autonomy in real-world scientific reasoning. By explicitly encoding uncertainty and recognising unfamiliar inputs, these agents become capable of detecting anomalies, and they begin to act independently: curating data, identifying patterns, and proposing hypotheses in complex clinical domains. This breakthrough reframes the role of AI in medicine. No longer confined to fixed-task classification or retrospective association, agentic AI systems can now act as autonomous collaborators in medical discovery. We validated this concept in cardiovascular
imaging, where agents independently conducted phenome-wide association studies, rediscovered known correlations, and surfaced novel phenotype-disease links with transparent, explainable logic.
With ORACLE, we aim to extend this paradigm to oncology, focusing on pancreatic cancer, a devastating disease with limited early detection and poor outcomes. Agents will begin with large-scale, multimodal clinical data: radiology, pathology, molecular reports, and labs, and autonomously curate and structure it into patient trajectories. Once organised, agents will explore the data landscape:
clustering phenotypes, linking imaging to molecular patterns, and testing hypotheses across cohorts. When normative data is available, they compare against population-wide baselines; when it is not, agents can use our generative methods to impute missing values and identify structure.
Running entirely on real clinical data within GDPR-compliant infrastructure, ORACLE will demonstrate that autonomous AI agents can produce publishable, clinically relevant insights. This PoC may not only advance cancer research but reshape how biomedical discovery is done: transforming it into an automated, data-driven process.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2026-POC

See all projects funded under this call

Host institution

FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBERG
Net EU contribution
€ 150 000,00
Address
FREYESLEBENSTRAßE 1
91058 Erlangen
Germany
Region
Bayern Mittelfranken Erlangen, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)